Viral Vectors in Gene Therapy
Top Cited Papers
Open Access
Abstract
Applications of viral vectors have found an encouraging new beginning in gene therapy in recent years. Significant improvements in vector engineering, delivery, and safety have placed viral vector-based therapy at the forefront of modern medicine. Viral vectors have been employed for the treatment of various diseases such as metabolic, cardiovascular, muscular, hematologic, ophthalmologic, and infectious diseases and different types of cancer. Recent development in the area of immunotherapy has provided both preventive and therapeutic approaches. Furthermore, gene silencing generating a reversible effect has become an interesting alternative, and is well-suited for delivery by viral vectors. A number of preclinical studies have demonstrated therapeutic and prophylactic efficacy in animal models and furthermore in clinical trials. Several viral vector-based drugs have also been globally approved.Keywords
This publication has 129 references indexed in Scilit:
- Immune responses to AAV vectors: overcoming barriers to successful gene therapyBlood, 2013
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancerNature Medicine, 2013
- Engineering HIV-1-Resistant T-Cells from Short-Hairpin RNA-Expressing Hematopoietic Stem/Progenitor Cells in Humanized BLT MicePLOS ONE, 2012
- Knockdown of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's diseaseThe Journal of Gene Medicine, 2011
- Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochlorideInvestigational New Drugs, 2010
- Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's MiceThe Journal of Neuroscience, 2010
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBMMolecular Therapy, 2009
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Journal of Clinical Investigation, 2008
- Silencing of human α-synuclein in vitro and in rat brain using lentiviral-mediated RNAiExperimental Neurology, 2006
- Packaging Capacity of Adeno-Associated Virus Serotypes: Impact of Larger Genomes on Infectivity and Postentry StepsJournal of Virology, 2005